BiotechTube
Home/HEPHAISTOS-Pharma/Frederic Caroff
FC

Frederic Caroff

Chief Executive Officer

HEPHAISTOS-Pharma

Therapeutic Areas

Oncology

HEPHAISTOS-Pharma Pipeline

DrugIndicationPhase
HEPHA-440Solid Tumors (e.g., Osteosarcoma)Preclinical
HEPHA-440 + aPD-1Solid tumors in combination with checkpoint inhibitorPreclinical

Leadership Team at HEPHAISTOS-Pharma

DM
Dr. Martine Caroff
Chief Scientific Officer, Co-Founder
PC
Pr. Charles Dumontet
Deputy Director, Co-Founder
DS
David Sourdive
Chairman of the Board
View full HEPHAISTOS-Pharma profile